Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase.

Tchivileva IE, Nackley AG, Qian L, Wentworth S, Conrad M, Diatchenko LB.

Mol Pain. 2009 Mar 16;5:13. doi: 10.1186/1744-8069-5-13.

3.

Catechol-O-methyltransferase and pain.

Kambur O, Männistö PT.

Int Rev Neurobiol. 2010;95:227-79. doi: 10.1016/B978-0-12-381326-8.00010-7. Review.

PMID:
21095465
4.

COMT genetic variants and pain.

Belfer I, Segall S.

Drugs Today (Barc). 2011 Jun;47(6):457-67. doi: 10.1358/dot.2011.47.6.1611895. Review.

PMID:
21695287
5.
6.

Janus molecule I: dichotomous effects of COMT in neuropathic vs nociceptive pain modalities.

Segall SK, Maixner W, Belfer I, Wiltshire T, Seltzer Z, Diatchenko L.

CNS Neurol Disord Drug Targets. 2012 May;11(3):222-35. Review.

7.
8.

Induction of cytotoxicity in melanoma cells through inhibition of catechol-O-methyltransferase.

Smit NP, Pavel S.

Biochem Pharmacol. 1995 Dec 22;50(12):1955-62. Review. No abstract available.

PMID:
8849320
9.

Human evidence of a supra-spinal modulating role of dopamine on pain perception.

Potvin S, Grignon S, Marchand S.

Synapse. 2009 May;63(5):390-402. doi: 10.1002/syn.20616. Review.

PMID:
19173266
Items per page

Supplemental Content

Write to the Help Desk